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Background: Brain glucose sensing may contribute to energy homeostasis control. The prefrontal cortex (PFC)
participates in the hedonic component of feeding control. As high-fat diets may disrupt energy homeostasis, we
evaluated in male Wistar rats whether intake of high-fat fish-oil diet modified cortical glucose extracellular levels
and the feeding induced by intracerebroventricular glucose or PFC glucoprivation.
Methods: Glucose levels in PFC microdialysates were measured before and after a 30-min meal. Food intake was
measured in animals receiving intracerebroventricular glucose followed, 30-min. later, by 2-deoxy-D-glucose injected
into the PFC.
Results: The fish-oil group showed normal body weight and serum insulin while fat pads weight and glucose levels were
increased. Baseline PFC glucose and 30-min. carbohydrates intake were similar between the groups. Feeding-induced
PFC glucose levels increased earlier and more pronouncedly in fish-oil than in control rats. Intracerebroventricular
glucose inhibited feeding consistently in the control but not in the fish-oil group. Local PFC glucoprivation with
2-DG attenuated glucose-induced hypophagia.
Conclusions: The present experiments have shown that, following food intake, more glucose reached the
prefrontal cortex of the rats fed the high-fat fish-oil diet than of the rats fed the control diet. However, when ad-
ministered directly into the lateral cerebral ventricle, glucose was able to consistently inhibit feeding only in the
control rats. The findings indicate that, an impairment of glucose transport into the brain does not contribute to
the disturbances induced by the high-fat fish-oil feeding.
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The homeostatic control of energy homeostasis operates
through peripheral signals integrated at the central nervous
system (CNS), which modulates the activity of hypothal-
amic anabolic and catabolic neurons [1]. The long-term
control depends on leptin and insulin signaling of body adi-
posity while the short-term control monitors hunger and
satiety through signaling by gastrointestinal hormones [2].
Furthermore, the hedonic component of energy balance
control exerts a pivotal modulation of the homeostatic influ-
ences on food intake [3,4]. Although of high physiological
importance to feeding behavior, the reward properties of* Correspondence: eliane.beraldi@gmail.com
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reproduction in any medium, provided the orfood may lead to excessive intake that surpasses the meta-
bolic needs and leads to obesity. Mesocorticolimbic struc-
tures, including the prefrontal cortex (PFC), have been
directly implicated in the hedonic aspect of feeding regula-
tion [5-7].
Besides the mentioned hormones, the nutrients them-
selves may play a role as signals to the CNS. We and
others have observed that central glucose administration
reduced feeding in rats [8-12]. Glucose has been shown
to modify the activity of both glucose-excited and
glucose-inhibited neurons, whose existence has been
demonstrated in the hypothalamus and also mesocorti-
colimbic structures [13,14]. Glucose signaling at these
areas has been attributed a potential role not only as an
acute satiety factor but also as a long-term feeding regu-
lator [15].al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the obesity epidemic and its comorbidities [16]. The
consumption of high-fat diets may affect the central
mechanisms of feeding regulation as well as peripheral
metabolism and the predominant fat type has been
shown to be a relevant aspect conditioning the diet ef-
fects. Animal studies have found that saturated and n-6
and n-9 polyunsaturated fatty acids (PUFAs) are more
involved in the genesis of insulin resistance, while n-3
PUFAs have been associated with less deleterious effects
and even amelioration of the aspects affected by the
other fats [17-21].
In rats, we have previously found that the long-term
intake of trans-fat diet or n-6 PUFAs diet impaired
hypothalamic insulin signaling and insulin hypophagia
while n-3 PUFA diet had no such effects [22,23]. Add-
itionally, n-6 PUFA diet caused neuronal activation of
orexigenic hypothalamic sites while n-3 PUFA diet in-
creased the activity of anorexigenic sites. On the other
hand, the n-3 diet impaired the serotonergic activity at
the hypothalamus [24,25].
The present work was aimed at evaluating whether the
consumption of high-fat diet enriched with fish oil
(source of n-3 PUFAs) modified PFC glucose extracellu-
lar levels as well as the feeding response to intracerebro-
ventricular glucose or to PFC glucoprivation.
Results
Body weight gain, white fat mass and fasting serum
glucose and insulin
No significant difference was observed between the
groups on body weight (p = 0.3838) while white fat mass
was higher in the fish-oil group than in the control
group (p = 0.0005). The levels of glucose were signifi-
cantly higher in fish-oil than in control rats (p = 0.016)
while insulin levels were similar between the groups
(Table 1).
Effect of food intake on extracellular levels of glucose in
PFC
For 30 minutes during microdialysates collection, the
rats had access to their respective diets added with con-
densed milk, in the proportion of 1 g of diet to 1.5 g ofTable 1 Body weight gain, fat depots weight, and serum
glucose and insulin levels of control and fish-oil rats
Control Fish-oil
Body weight (g) 414 ± 9 (14) 401 ± 12 (14)
†White fat (g/100 g) 2.26 ± 0.14 (14) 3.39 ± 0.23* (14)
Glucose (mg/dl) 105.1 ± 3.7 (11) 130.8 ± 8.7* (12)
Insulin (ng/ml) 0.60 ± 0.07 (10) 0.52 ± 0.04 (9)
Values are expressed as means ± S.E.M.
†Sum of retroperitoneal, mesenteric and gonadal fat depots.
*p < 0.05 vs. Control. () number of animals.condensed milk. Table 2 shows the composition of the
condensed milk diets. The acute food mass ingestion
was similar between the control (2.84 ± 0.40 g) and the
fish-oil (2.64 ± 0.55 g) group. The intakes of carbohy-
drate, protein and fat, as well as energy intakes, were
also similar between the groups. However, dietary fiber
intake was lower in the fish-oil group in relation to the
control group (p < 0.0001).
Baseline values of glucose levels in the PFC were similar
between control (217 ± 42 ng/10 μl) and fish-oil-group
rats (166 ± 29 ng/10 μl, p = 0.38).
The chronic diet treatment had a significant interaction
with sampling time after acute food intake (F(10,330) =
2.195, p = 0.017). The PFC glucose levels were significantly
increased in control animals at the times 60′, 90′, 120′,
and 150′ after food presentation, with increments of 24%
to 35%.
In the fish-oil group, the extracellular levels of glucose
were significantly increased at 30 (39% increase) and 60
(28% increase) minutes after food presentation. The
levels of glucose were significantly higher in the fish-oil
group than in the control group at the time 30 minutes
after food presentation (p = 0.014, Figure 1). The area
under the curve of glucose levels over time was similar
between control (8720 ± 1268) and fish-oil groups (8737 ±
1298, p = 0.993).Effects of intracerebroventicular glucose with or without
intracortical 2-deoxy-D-glucose (2-DG) on food intake of
control and fish-oil groups
Two hours after the injections, a significant diet effect
(F(3,69) = 6.573, p = 0.012) was detected. The fish-oil
group injected with vehicle-vehicle had an ingestion sig-
nificantly higher than that of the respective control
group (p = 0.022, Figure 2). The injection of glucose-
vehicle caused a small but significant inhibition of 2-h
ingestion (p = 0.008). No significant diet versus injection
interaction was detected.
A significant injection effect was detected at time 12
hours (F(3,70) = 4.036, p = 0.010). In the control group,
food intake was significantly inhibited 12 hours after the
i.c.v. injection of glucose (p = 0.039), and the intracorti-
cal injection of 2-DG, performed 30 minutes after i.c.v.
glucose, failed to modify glucose-induced hypophagia
(p = 0.041). The intracortical injection of 2-DG after i.c.
v. vehicle also inhibited 12-h feeding (p = 0.009). No sig-
nificant effects were observed in the fish-oil group. No
significant diet versus injection interaction was detected.
Anova showed a significant effect of injections (F(3,69) =
3.213, p = 0.054). The post- hoc test showed that the 24-
h intake of the fish-oil group was lower than that of the
control group (p = 0.036). In the control group, the i.c.v.
injection of glucose promoted a significant inhibition of
Table 2 Composition of the control and fish-oil diets available during the acute experiments
Treatment diets (%) †Condensed milk diets (%) ‡30 min. food intake (g)
Group Control Fish-oil Control Fish-oil Control Fish-oil
Kcal/100 g 287.7 364.3 310.1 340.7 8.81 ± 1.24 8.99 ± 1.87
Carbohydrate 39.8 28.9 48.9 44.6 1.39 ± 0.20 1.18 ± 0.24
Fat 4.5 17.5 6.9 12.1 0.20 ± 0.03 0.32 ± 0.07
Protein 22 22.8 13.3 13.6 0.38 ± 0.05 0.36 ± 0.07
Dietary Fiber 13.8 3.7 5.5 1.5 0.16 ± 0.02 0.04 ± 0.01*
†Composition of the treatment diets blended with condensed milk (1:1.5; g:g).
‡n = 21 (control) and 14 (fish-oil).
Values are expressed as means ± S.E.M.; *p < 0.05 vs. Control.
de Sousa et al. Lipids in Health and Disease 2013, 12:188 Page 3 of 9
http://www.lipidworld.com/content/12/1/18824-h food intake (p = 0.009). The intracortical injection
of 2-DG attenuated glucose-induced hypophagia, since
intake was not significantly different from the vehicle-
vehicle group (0.063). The intake was also significantly
inhibited by the PFC injection of 2-DG after i.c.v. vehicle
(p = 0.004). No significant injections effects were detected
in the fish-oil group.
Verification of dialysis membrane and intracortical
cannula positioning
Figure 3 shows a representative photograph of a brain
section showing the positioning of the microdialysis
membrane. Data analysis included only those rats in
which the microdialysis membrane was correctly located
in the PFC. The same verification was made for the
placement of the guide cannula for intracortical injec-
tions (not shown).
Discussion
In the present study, we observed that rats fed for 8
weeks with the fish-oil diet oil had increased fat pads
weight with normal body weight. Normal body weight
has been shown in mice fed n3-rich diet and ascribed to50
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oxidation and diminished expression of lipogenic factors
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the increased fat pads weight observed in this study.
Increased expression of proopiomelanocortin (POMC)
and reduced expression of neuropeptide Y (NPY) at the
hypothalamus have been observed after fish-oil diets
[28]. In our laboratory, we have described that the
feeding-induced neuronal activation, as evidenced by c-
Fos expression, occurred predominantly in the lateral
portion of the arcuate nucleus, as well as the ventro-
medial hypothalamus (VMH), and paraventricular nu-
cleus of hypothalamus (PVH), hypothalamic areas
expressing anorexigenic neuropeptides [24]. These find-
ings agree with the present observation of decreased
daily food intake of the fish-oil rats.
Available data on the effects of n3-PUFA on body
weight and composition in humans are controversial. Al-
though it has been suggested that the beneficial effects
of n-3 PUFAs are restricted to lean individuals [29], in
overweight/obese subjects, n-3 PUFA supplementation
improved the body weight loss induced by caloric
restriction [30] while it improved the adipose mass0 120 150 180 210 240
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Figure 2 Food intake of control and fish-oil groups after 2-DG, glucose or vehicle injections. Food intake of control (A) and fish-oil (B)
groups, 2, 12, and 24 hours after injections of vehicle-vehicle (N = 13-14 and 11–12), glucose-vehicle (N = 10-11 and 8–9), glucose-2DG (N = 11
and 9) or vehicle-2DG (N = 8 and 6–7). 2-DG or vehicle were injected in the PFC 30 min. after the i.c.v. injection of either glucose or vehicle.
*p < 0.05 vs. vehicle-vehicle. #p < 0.05 vs. control.
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expenditure [31]. On the other hand, eicosapentaenoic
acid/docosahexaenoic acid supplementation failed to
modify the response of overweight individuals to nutri-
tional/exercise intervention [32]. We have previously
shown that n-3 PUFAs comprise 73% of the total fatty
acids content of the fish-oil diet used in the present
study, 39% of which is eicosapentaenoic acid and 24% is
docosahexaenoic acid, while the control diet has only 7%
as n-3 PUFAs [23].
The fish-oil group presented hyperglycemia with nor-
mal insulinemia, indicating insulin resistance. This con-
trasts with many studies that have associated the
consumption of n-3 PUFAs to improved glycemic con-
trol and insulin sensitivity [33,34]. Diminished adipo-
cytes size has been reported in obese/diabetic db/db
mice after high-fat n-3 diet [35], what would have apositive effect on adipokines secretion and insulin sensi-
tivity [36].
On the other hand, findings similar to the present
ones, of insulin resistance after n-3 PUFAs treatment
have been found in other studies in rodents [28] and
humans [37,38]. In diabetic hypertensive humans, sup-
plementation with eicosapentaenoic acid/docosahexae-
noic acid induced fasting hyperglycemia [38,39] while
hyperlipidemic humans showed increased insulinemia
with normal glycemia [37].
We observed that the fasting baseline levels of glucose
in PFC microdialysates were not affected by the long-term
intake of the fish-oil diet. We then performed experiments
to ascertain whether the intake of food modified the level
of glucose recovered in the microdialysates. The diets
consumed acutely had asimilar carbohydrates content
although they differed in fat and fiber content.
Figure 3 Localization of the microdialysis membrane in the
prefrontal cortex.
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PFC glucose in both the control and the fish-oil groups.
Feeding-induced increase of glucose levels has also been
reported in microdialysates of the ventromedial and the
lateral hypothalamus of normal rats [40,41]. The fish-oil
group showed a more pronounced increase and an earl-
ier response, in comparison to the control group. This
event could not be explained considering the carbohy-
drate content of the diet, since the same amount of this
macronutrient was ingested by both groups during the
30-minutes meal. Although the control diet had higher
fiber content than that of the fish-oil diet, the small
amount of fiber ingested by both groups was probably
not effective in producing a relevant difference in nutri-
ents absorption. Furthermore, since the fish-oil group
ate more fat than the control group, it is likely that the
groups had similar carbohydrates absorption, as the fat
content of the diet decreases glycemic index [42].
The present observations agree with the finding that
an oral glucose overload increased striatum microdia-
lysates glucose more pronouncedly in streptozotocin-
diabetic than in control rats [43]. On the other hand,
glucose flux to the parietal cortex has been found to
be decreased in streptozotocin-diabetic rats, regardless
the glycemic level [44]. Reduced glucose transport into
the brain has also been reported in diabetic rats with
normalization by glycemic control with chronic insulin [45].
Although we have not measured the feeding-induced
glycemic levels, we observed fasting hyperglycemia in the
fish-oil group, suggesting that the different PFC response
to feeding between control and fish-oil groups could be
related to their glycemic differences. There are findings
supporting the view that glycemic levels influence theextracellular levels of glucose in the brain. For example,
microdialysate glucose levels in the frontoparietal cortex
of rats have been shown to be linked to the glycemic vari-
ations induced by venous glucose infusion [46]. Similar
findings were obtained in the cingulate cortex, in which
extracellular glucose, as measured by glucose-sensitive mi-
croelectrodes, paralleled the glycemic levels produced by
intraperitoneal glucose [47]. In humans with severe brain
injury, a positive correlation between glycemia and brain
microdialysate levels of glucose has been reported in
non-injured unlike injured areas [48]. On the other
hand, findings pointing to the absence of a direct link
between plasma and brain extracellular glucose levels
have also been provided. In normal rats, such demon-
stration has been made for feeding-induced glucose
levels in the hypothalamus [40] and glucose injection-
induced extracellular levels in the hippocampus [49], as
evaluated by microdialysis.
The finding that glucose increased efficiently in the
PFC of the fish-oil group after feeding contrasts with the
mild feeding inhibition by i.c.v. glucose in this group, in
comparison to the control group.
Unlike the prefrontal cortex, the hypothalamus has been
largely studied with respect to the mechanisms of glucose
interaction with neurons. In this region, glucose-inhibited
and glucose-excited neurons have been characterized,
both types displaying abnormal response to glucose varia-
tions in obese rats. Particularly in the medial hypothal-
amus, increment of glucose levels has been shown to
decrease firing rate of NPY-expressing glucose-inhibited
neurons while increasing that of POMC-expressing neu-
rons, thus leading to feeding inhibition [13,50-52]. Thus,
failure of i.c.v. glucose to consistently inhibit feeding in
the fish-oil group could rely on impaired glucose action
on these neurons. This notion is compatible with the
demonstration that glucose transporter 2 null mice be-
came hyperphagic, had disrupted hypothalamic neuropep-
tides expression, and failed to respond with hypophagia to
either i.c.v. or intraperitoneal glucose [53].
The PFC has been found to have neurons whose activ-
ity changed in response to glucose, the majority of which
(69%) has been found to be glucose-inhibited, although
glucose-excited neurons have also been identified. These
neurons have been implied in the feeding control influ-
ences exerted by the prefrontal cortex [14]. Although
their phenotype has not yet been ascertained, it is likely
that these neurons participate in the mechanisms affect-
ing the hedonic component food intake control. The
present finding of attenuation of glucose-induced hypo-
phagia by PFC glucoprivation indicates that local glucose
metabolism may be relevant to the glucose effect. In this
respect, it is noteworthy that we have observed, in a
previous study in hyperglycemic rats fed saturated high-
fat diet, exacerbated increase of glucose levels in the
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glucose-induced hypophagia [54].
Besides glucose, fatty acids signaling in the central ner-
vous system has been associated with inhibition of NPY
neurons and decreased feeding and hepatic glucose pro-
duction [55]. Importantly, consumption of high-fat diet
has been shown to impair the ability of i.c.v. oleic acid
to induce these effects [56]. It is possible to suggest that
these defects induced by high-fat feeding may have im-
paired glucose effects as well. In humans, euglycemic or
hyperglycemic conditions induced activation of medial
PFC, what was associated with less interest in food stim-
uli, and that the PFC activation was impaired in obese
individuals [57].
In the present study, the PFC injection of 2-DG inhib-
ited 12-h and 24-h food intake in the control but not in
the fish-oil group. This agrees with the demonstration
of attenuation, in high fat-fed rats, of the hyperphagic
response to glucoprivation induced by either systemic or
IV ventricle injection of 5-thio-D-glucose [58].
Although generalized glucoprivation, as induced by ei-
ther peripheral or i.c.v. 2-DG, is known to induce feed-
ing, the response to localized injection is controversial,
as absence of an effect and both feeding inhibition and
stimulation have been reported after 2-DG injection into
various brain sites [59,60]. The physiological significance
of the present finding of feeding inhibition by 2-DG local
PFC administration is not clear. However, the present
concomitant observation of attenuation of this effect in
the fish-oil group strongly suggests that glucose sensing is
disrupted in this situation. Additional experiments are
warranted to elucidate the part played by glucose metabol-
ism in this brain site and the mechanisms affected by fish
oil consumption.
Conclusions
The present experiments have shown that, following
food intake, more glucose reached the prefrontal cortex
of the rats fed the high-fat fish-oil diet than of the rats
fed the control diet. However, when administered dir-
ectly into the lateral cerebral ventricle, glucose was able
to consistently inhibit feeding only in the control rats.
The findings indicate that, an impairment of glucose
transport into the brain does not contribute to the dis-
turbances induced by the high-fat fish-oil feeding.
Methods
Animals and diets
All animal experiments were performed in accordance
with the directives of the Brazilian Council on Animal
Research and the Committee on Animal Research Ethics
of the Federal University of Sao Paulo. Male Wistar rats
were maintained under controlled conditions of ligh-
ting (12:12 h light–dark cycle, lights on at 6 am) andtemperature (24 ± 1°C). At two-months of age, the rats
were randomly assigned to receive standard chow diet
(15% energy from fat; Nuvilab CR1, Nuvital, PR, Brazil)
or high-fat diet prepared by adding 20% (w/w) of fish oil
(ROPUFA® ‘75′ω-3, Roche, DSM Nutritional Products,
Brazil) to the control diet (fish-oil group: 52% energy
from fat). The high-fat diet also contained (w/w) 10%
sucrose and 20% casein, to obtain a protein/energy ratio
similar to that of the control diet. The composition of
the treatment diets is shown in Table 2. The fatty acids
composition of the diets has been previously published
[23]. The diet treatments were applied for 8 weeks.
Placement of intracerebroventricular and PFC cannulas
After the 8 weeks on the diet treatments, the rats were
anaesthetized (ketamine/xylazine 66.6/13.3 mg/Kg, i.p.)
for microdialysis and intracortical guide cannulas
introduction. They were stereotaxically implanted with
21-gauge guide cannulas aimed at the PFC (3.2 mm
anterior and −0.6 mm lateral to bregma and 1.5 mm
below dura mater). The lateral ventricle guide cannula
was placed −0.9 mm anterior and 1.5 mm lateral to
bregma and 3 mm below dura mater [61]. The cannu-
las were secured to the skull with stainless steel screws
and dental cement.
Effect of food intake on extracellular glucose in PFC
Seven days after surgery, at 4–5 pm and under slight
anesthesia, the rats had a concentric custom-made mi-
crodialysis probe (effective membrane length: 4.0 mm,
13000 Da cut-off ) inserted through the PFC guide can-
nula and fixed to it with dental cement. Probe in vitro
glucose recovery was 9 ± 1.82%. Details of probe con-
struction were as previously described [62].
The rats were connected to a swivel system and the
probe was attached to a microinjection pump, allowing
continuous perfusion with artificial cerebrospinal fluid
(145 mM NaCl, 2.2 mM KCl, 1.0 mM MgCl2, 1.2 mM
CaCl2, 2.0 mM Na2HPO4, pH 7.4), at a flow rate of
1.5 μl/minute. Overnight perfusion was performed to
allow equilibration. Rats were fasted overnight.
On the next morning, the collection of 30-min dialysate
samples started at 8 am. Three baseline samples were col-
lected and a known amount of food was offered. The
acute food mixture consisted of powdered control or fish-
oil diets to which condensed milk was added in the pro-
portion of 1:1.5 (Table 2). The amount of food ingested
was measured after thirty minutes, coinciding with the
collection of one microdialysate sample. After this 30-min.
meal period, food was withdrawn and 7 additional micro-
dialysate samples were collected.
At the end of the experiments, the brains were sliced
and photographed for confirmation of membrane loca-
tion in the PFC.
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tissue mass
The animals were killed by decapitation after an overnight
fast and trunk blood was collected and stored at -80°C.
Serum glucose was measured enzymatically (glucose oxi-
dase GOD-Trinder, Labtest Diagnóstica, Lagoa Santa,
MG, Brazil) and serum insulin was measured by ELISA
(Rat/Mouse Insulin ELISA, Millipore). White adipose tis-
sue depots (epididymal, mesenteric and retroperitoneal)
were dissected and weighed.Measurement of glucose content in microdialysates
Microdialysate samples were immediately stored at
-20°C and glucose analysis was performed no later than
24 hours by the method described above, using 10 μl of
microdialysate.Feeding response to intracerebroventriular glucose and
effect of intracortical 2-deoxy-D-glucose (2-DG)
The animals were implanted with two brain guide cannu-
las, one aimed at the PFC, as described above, and the
other aimed at the lateral ventricle (−0.9 mm anterior and
1.5 mm lateral to bregma, and 3 mm below dura mater).
The intracerebroventricular (i.c.v.) cannula placement was
confirmed by a positive drinking response after adminis-
tration of angiotensin II (20 ng).
After six days, the rats were fasted from 12:00 to
17:00 h and then received the i.c.v. injection (1 μl in
1 min.) of either vehicle (artificial cerebrospinal fluid)
or glucose (20 μg) followed, 30 min. later, by the intra-
cortical injection of either vehicle or 2-DG (100 μg).
Immediately after the second injection, a known
amount of food was presented. The food consisted of
the conventional pelleted control or fish-oil diet the an-
imals received during the 2 months of diet treatment.
Ingestion was measured 2 h, 12 h, and 24 h after the
injections.Statistical analysis
The results are expressed as means ± SEM. Microdialy-
sate glucose levels are expressed as percentage of the
mean basal level, obtained by averaging the three base-
line samples, collected before food presentation. Dialys-
ate glucose data were analyzed by two-way repeated
measures Anova followed by LSD test for multiple com-
parisons. Food intakes after the injections of vehicle, glu-
cose, or 2-DG were compared by two-way Anova and
LSD post-hoc test. The area under the curve relating
glucose levels to time was calculated by the trapezoidal
rule. Statistical significance was set at p < 0.05. The stat-
istical analyses were performed using the software Statis-
tica 12 (Statsoft, Inc., 2013).Abbreviations
2-DG: 2-deoxy-D-glucose; CNS: Central nervous system;
i.c.v.: Intracerebroventricular; NPY: Neuropeptide Y; PFC: Prefrontal cortex;
POMC: Proopiomelanocortin; PPAR-α: Peroxisome proliferator activator
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